COVID 19 Drug and Vaccine Pipeline Current Status Report: May 2020 Update
The May 2020 updated COVID-19 pipeline report presents most recent updates on drug candidates and vaccine candidates that will potentially reach the market in the next 2 years.
As of May 2020, the COVID-19 pipeline remains robust with over 150 therapeutic and Vaccine candidates under development. 150 companies including large scale and small scale companies are participating in the development of treatment and vaccination against novel corona virus infected COVID 19.
The report provides complete details of pipeline drugs including the development phase, companies involved, clinical trial developments, and other details. Further, the report also provides COVID 19 drug development history, latest news, and other developments.
Snapshot-
COVID-19 pipeline comprises of 153 drug candidates under development as of April 2020. The pipeline is characterized by presence of both large scale companies and small players. Large companies including Novartis, Pfizer, Zydus, Roche, Sanofi and GlaxoSmithKline continue to invest in treatment options vaccination candidates.
Among pre-clinical and research phase candidates, several companies are looking for partnering with other companies or universities to advance their research studies.
‘Interleukin 6 inhibitors’ is among the most researched types in the pipeline.
Around 77 of 153 candidates are new molecular entities.
Of the 153 drug candidates in development, 10 drug/vaccine candidates advanced to Phase 3 while 13 candidates are in Phase 2. Five candidates are in Phase 1 and 42 candidates are in preclinical study phase. Further, the number of drug and vaccine candidates in research study phase stood at 83.
Scope:
As of May 2020, the COVID-19 pipeline remains robust with over 150 therapeutic and Vaccine candidates under development. 150 companies including large scale and small scale companies are participating in the development of treatment and vaccination against novel corona virus infected COVID 19.
The report provides complete details of pipeline drugs including the development phase, companies involved, clinical trial developments, and other details. Further, the report also provides COVID 19 drug development history, latest news, and other developments.
Snapshot-
COVID-19 pipeline comprises of 153 drug candidates under development as of April 2020. The pipeline is characterized by presence of both large scale companies and small players. Large companies including Novartis, Pfizer, Zydus, Roche, Sanofi and GlaxoSmithKline continue to invest in treatment options vaccination candidates.
Among pre-clinical and research phase candidates, several companies are looking for partnering with other companies or universities to advance their research studies.
‘Interleukin 6 inhibitors’ is among the most researched types in the pipeline.
Around 77 of 153 candidates are new molecular entities.
Of the 153 drug candidates in development, 10 drug/vaccine candidates advanced to Phase 3 while 13 candidates are in Phase 2. Five candidates are in Phase 1 and 42 candidates are in preclinical study phase. Further, the number of drug and vaccine candidates in research study phase stood at 83.
Scope:
- 153 drugs and vaccines, 150+ companies covered
- New molecular entities identified
- Pre-clinical, research, clinical stage products analyzed
- Drug, Mechanism of Action, Phase, Co-Developer, Originator, Synonyms, Route of Administration, New Molecular Entity details provided
- Further, Current Status, Drug details, trial details are provided
- Latest market and pipeline developments are provided in the report
1 TABLE OF CONTENTS
1.1 List of Figures
1.2 List of Tables
2 EXECUTIVE SUMMARY
2.1 Disease Overview
2.2 Pipeline Snapshot
2.3 Pipeline Drugs by Phase
2.4 Pipeline Drugs by New Molecular Entity
2.5 Pipeline Drugs by Mechanism of Action
3 PHASE 3 COVID-19 DRUG CANDIDATES IN ACTIVE DEVELOPMENT
3.1 AstraZeneca Plc COVID-19 Pipeline
3.2 Novartis AG COVID-19 Pipeline
3.3 Gilead Sciences Inc COVID-19 Pipeline
3.4 FUJIFILM Toyama Chemical Co. Ltd COVID-19 Pipeline
3.5 Vanda Pharmaceuticals Inc COVID-19 Pipeline
3.6 Roche AG COVID-19 Pipeline
3.7 OncoImmune Inc COVID-19 Pipeline
3.8 Sanofi SA COVID-19 Pipeline
3.9 Swedish Orphan Biovitrum AB COVID-19 Pipeline
3.10 CytoDyn Inc COVID-19 Pipeline
4 PHASE 2 COVID-19 DRUG CANDIDATES IN ACTIVE DEVELOPMENT
4.1 Eli Lilly and Company COVID-19 Pipeline
4.2 Karyopharm Therapeutics Inc COVID-19 Pipeline
4.3 Synairgen Plc COVID-19 Pipeline
4.4 Bristol-Myers Squibb Co. COVID-19 Pipeline
4.5 Tianjin CanSino Biotechnology COVID-19 Pipeline
4.6 Kinevant Sciences Ltd COVID-19 Pipeline
4.7 Vitaeris Inc COVID-19 Pipeline
4.8 Relief Therapeutics Holdings COVID-19 Pipeline
4.9 Viriom Inc COVID-19 Pipeline
4.10 CalciMedica Inc COVID-19 Pipeline
4.11 Apeiron Biologics GmbH COVID-19 Pipeline
4.12 Ansun Biopharma Inc COVID-19 Pipeline
4.13 I-MAB Biopharma Co Ltd COVID-19 Pipeline
5 PHASE 1 COVID-19 DRUG CANDIDATES IN ACTIVE DEVELOPMENT
5.1 Moderna Therapeutics Inc COVID-19 Pipeline
5.2 Ridgeback Biotherapeutics LP COVID-19 Pipeline
5.3 BioCryst Pharmaceuticals Inc COVID-19 Pipeline
5.4 Inovio Pharmaceuticals Inc COVID-19 Pipeline
5.5 InflaRx NV COVID-19 Pipeline
6 PRE-CLINICAL COVID-19 DRUG CANDIDATES IN ACTIVE DEVELOPMENT
6.1 AIM ImmunoTech Inc COVID-19 Pipeline
6.2 Arcturus Therapeutics Holdings Inc COVID-19 Pipeline
6.3 ARMS Pharmaceutical LLC COVID-19 Pipeline
6.4 Mateon Therapeutics Inc COVID-19 Pipeline
6.5 Beyond Air Inc COVID-19 Pipeline
6.6 BioNTech SE COVID-19 Pipeline
6.7 Can-Fite Biopharma Ltd COVID-19 Pipeline
6.8 Clover Biopharmaceuticals COVID-19 Pipeline
6.9 Cocrystal Pharma Inc COVID-19 Pipeline
6.10 Eiger BioPharmaceuticals Inc COVID-19 Pipeline
6.11 Eli Lilly and Company COVID-19 Pipeline
6.12 Ennaid Therapeutics LLC COVID-19 Pipeline
6.13 Epitopoietic Research Corporation COVID-19 Pipeline
6.14 EpiVax Inc COVID-19 Pipeline
6.15 eTheRNA Immunotherapies NV COVID-19 Pipeline
6.16 FibroGenesis COVID-19 Pipeline
6.17 GigaGen Inc COVID-19 Pipeline
6.18 Heat Biologics Inc COVID-19 Pipeline
6.19 IBio Inc COVID-19 Pipeline
6.20 Immunic Inc COVID-19 Pipeline
6.21 IMV Inc COVID-19 Pipeline
6.22 INTELLiSTEM Technologies Inc COVID-19 Pipeline
6.23 Medicago Inc COVID-19 Pipeline
6.24 MedinCell S.A. COVID-19 Pipeline
6.25 BioSig Technologies Inc COVID-19 Pipeline
6.26 Novavax Inc COVID-19 Pipeline
6.27 OyaGen Inc COVID-19 Pipeline
6.28 PDS Biotechnology Corporation COVID-19 Pipeline
6.29 Primmune Therapeutics COVID-19 Pipeline
6.30 SAB Biotherapeutics COVID-19 Pipeline
6.31 Shanghai Junshi Biosciences COVID-19 Pipeline
6.32 Sorrento Therapeutics Inc COVID-19 Pipeline
6.33 Stabilitech Biopharma Ltd COVID-19 Pipeline
6.34 Starpharma Holdings Limited COVID-19 Pipeline
6.35 Stemirna Therapeutics Co Ltd COVID-19 Pipeline
6.36 Tonix Pharmaceuticals Holding Corp. COVID-19 Pipeline
6.37 Vaxart Inc COVID-19 Pipeline
6.38 VBI Vaccines COVID-19 Pipeline
6.39 Vir Biotechnology Inc COVID-19 Pipeline
6.40 Zydus Cadila COVID-19 Pipeline
7 RESEARCH COVID-19 DRUG CANDIDATES IN ACTIVE DEVELOPMENT
7.1 48Hour Discovery Inc
7.2 AbCellera Biologics Inc
7.3 Active Motif
7.4 Adaptive Biotechnologies Inc
7.5 AdaptVac
7.6 Airway Therapeutics Inc
7.7 AJ Vaccines
7.8 Akers Biosciences Inc
7.9 Akshaya Bio Inc
7.10 Alkido Pharma Inc
7.11 Altimmune Inc
7.12 Amarillo Biosciences Inc
7.13 Array BioPharma Inc
7.14 Axon Neuroscience SE
7.15 Beroni group
7.16 Biocad
7.17 Bioxytran Inc
7.18 Bold Therapeutics Inc
7.19 Cell-Point LLC
7.20 Celltrion Inc
7.21 CEL-SCI Corporation
7.22 Cobra Biologics Ltd
7.23 Codagenix Inc
7.24 CureVac AG
7.25 Cytovia Therapeutics
7.26 Dyadic International Inc
7.27 Emergent BioSolutions Inc
7.28 Entos Pharmaceuticals Inc
7.29 EpiVax Inc
7.30 Exscientia Ltd
7.31 Generex Biotechnology Corporation
7.32 GeoVax Labs
7.33 Grifols SA
7.34 HaloVax LLC
7.35 Hetero Labs
7.36 ImmunityBio Inc
7.37 ImmunoPrecise Antibodies Ltd
7.38 Imophoron Ltd
7.39 Innovation Pharmaceuticals Inc
7.40 Iontas
7.41 IVIEW Therapeutics Inc
7.42 Kali-extracts Inc
7.43 Kamada Ltd
7.44 Kleo Pharmaceuticals Inc
7.45 Ligandal Inc
7.46 LineaRx Inc
7.47 Mabpharm Ltd
7.48 Mateon Therapeutics Inc
7.49 NanoViricides Inc
7.50 Nascent Biotech Inc
7.51 Neurimmune AG
7.52 NuGenerex Immuno-Oncology Inc
7.53 OliX Pharmaceuticals Inc
7.54 Ology Bioservices Inc
7.55 OncoSec Medical Inc
7.56 Pfizer Inc
7.57 Pneumagen Ltd
7.58 Q BioMed Inc
7.59 Qurient Co Ltd
7.60 Regeneron Pharmaceuticals Inc
7.61 Resverlogix Corp
7.62 Sanofi SA
7.63 Sirnaomics Inc
7.64 Sirona Biochem Corp
7.65 SmartPharm Therapeutics Inc
7.66 Soligenix Inc
7.67 Sorrento Therapeutics Inc
7.68 Sosei Group Corporation
7.69 Takeda Pharmaceutical Company Ltd
7.70 Takis Biotech
7.71 Themis Bioscience GmBH
7.72 Ufovax Inc
7.73 United Biomedical Inc
7.74 Vanda Pharmaceuticals Inc
7.75 Vaxil BioTherapeutics Ltd
7.76 Vir Biotechnology Inc
7.77 Viravaxx AG
7.78 WuXi Biologics Inc
7.79 XORTX Therapeutics Inc
8 APPENDIX
8.1 ABOUT VPA RESEARCH
8.2 SOURCES AND RESEARCH METHODOLOGY
1.1 List of Figures
1.2 List of Tables
2 EXECUTIVE SUMMARY
2.1 Disease Overview
2.2 Pipeline Snapshot
2.3 Pipeline Drugs by Phase
2.4 Pipeline Drugs by New Molecular Entity
2.5 Pipeline Drugs by Mechanism of Action
3 PHASE 3 COVID-19 DRUG CANDIDATES IN ACTIVE DEVELOPMENT
3.1 AstraZeneca Plc COVID-19 Pipeline
3.2 Novartis AG COVID-19 Pipeline
3.3 Gilead Sciences Inc COVID-19 Pipeline
3.4 FUJIFILM Toyama Chemical Co. Ltd COVID-19 Pipeline
3.5 Vanda Pharmaceuticals Inc COVID-19 Pipeline
3.6 Roche AG COVID-19 Pipeline
3.7 OncoImmune Inc COVID-19 Pipeline
3.8 Sanofi SA COVID-19 Pipeline
3.9 Swedish Orphan Biovitrum AB COVID-19 Pipeline
3.10 CytoDyn Inc COVID-19 Pipeline
4 PHASE 2 COVID-19 DRUG CANDIDATES IN ACTIVE DEVELOPMENT
4.1 Eli Lilly and Company COVID-19 Pipeline
4.2 Karyopharm Therapeutics Inc COVID-19 Pipeline
4.3 Synairgen Plc COVID-19 Pipeline
4.4 Bristol-Myers Squibb Co. COVID-19 Pipeline
4.5 Tianjin CanSino Biotechnology COVID-19 Pipeline
4.6 Kinevant Sciences Ltd COVID-19 Pipeline
4.7 Vitaeris Inc COVID-19 Pipeline
4.8 Relief Therapeutics Holdings COVID-19 Pipeline
4.9 Viriom Inc COVID-19 Pipeline
4.10 CalciMedica Inc COVID-19 Pipeline
4.11 Apeiron Biologics GmbH COVID-19 Pipeline
4.12 Ansun Biopharma Inc COVID-19 Pipeline
4.13 I-MAB Biopharma Co Ltd COVID-19 Pipeline
5 PHASE 1 COVID-19 DRUG CANDIDATES IN ACTIVE DEVELOPMENT
5.1 Moderna Therapeutics Inc COVID-19 Pipeline
5.2 Ridgeback Biotherapeutics LP COVID-19 Pipeline
5.3 BioCryst Pharmaceuticals Inc COVID-19 Pipeline
5.4 Inovio Pharmaceuticals Inc COVID-19 Pipeline
5.5 InflaRx NV COVID-19 Pipeline
6 PRE-CLINICAL COVID-19 DRUG CANDIDATES IN ACTIVE DEVELOPMENT
6.1 AIM ImmunoTech Inc COVID-19 Pipeline
6.2 Arcturus Therapeutics Holdings Inc COVID-19 Pipeline
6.3 ARMS Pharmaceutical LLC COVID-19 Pipeline
6.4 Mateon Therapeutics Inc COVID-19 Pipeline
6.5 Beyond Air Inc COVID-19 Pipeline
6.6 BioNTech SE COVID-19 Pipeline
6.7 Can-Fite Biopharma Ltd COVID-19 Pipeline
6.8 Clover Biopharmaceuticals COVID-19 Pipeline
6.9 Cocrystal Pharma Inc COVID-19 Pipeline
6.10 Eiger BioPharmaceuticals Inc COVID-19 Pipeline
6.11 Eli Lilly and Company COVID-19 Pipeline
6.12 Ennaid Therapeutics LLC COVID-19 Pipeline
6.13 Epitopoietic Research Corporation COVID-19 Pipeline
6.14 EpiVax Inc COVID-19 Pipeline
6.15 eTheRNA Immunotherapies NV COVID-19 Pipeline
6.16 FibroGenesis COVID-19 Pipeline
6.17 GigaGen Inc COVID-19 Pipeline
6.18 Heat Biologics Inc COVID-19 Pipeline
6.19 IBio Inc COVID-19 Pipeline
6.20 Immunic Inc COVID-19 Pipeline
6.21 IMV Inc COVID-19 Pipeline
6.22 INTELLiSTEM Technologies Inc COVID-19 Pipeline
6.23 Medicago Inc COVID-19 Pipeline
6.24 MedinCell S.A. COVID-19 Pipeline
6.25 BioSig Technologies Inc COVID-19 Pipeline
6.26 Novavax Inc COVID-19 Pipeline
6.27 OyaGen Inc COVID-19 Pipeline
6.28 PDS Biotechnology Corporation COVID-19 Pipeline
6.29 Primmune Therapeutics COVID-19 Pipeline
6.30 SAB Biotherapeutics COVID-19 Pipeline
6.31 Shanghai Junshi Biosciences COVID-19 Pipeline
6.32 Sorrento Therapeutics Inc COVID-19 Pipeline
6.33 Stabilitech Biopharma Ltd COVID-19 Pipeline
6.34 Starpharma Holdings Limited COVID-19 Pipeline
6.35 Stemirna Therapeutics Co Ltd COVID-19 Pipeline
6.36 Tonix Pharmaceuticals Holding Corp. COVID-19 Pipeline
6.37 Vaxart Inc COVID-19 Pipeline
6.38 VBI Vaccines COVID-19 Pipeline
6.39 Vir Biotechnology Inc COVID-19 Pipeline
6.40 Zydus Cadila COVID-19 Pipeline
7 RESEARCH COVID-19 DRUG CANDIDATES IN ACTIVE DEVELOPMENT
7.1 48Hour Discovery Inc
7.2 AbCellera Biologics Inc
7.3 Active Motif
7.4 Adaptive Biotechnologies Inc
7.5 AdaptVac
7.6 Airway Therapeutics Inc
7.7 AJ Vaccines
7.8 Akers Biosciences Inc
7.9 Akshaya Bio Inc
7.10 Alkido Pharma Inc
7.11 Altimmune Inc
7.12 Amarillo Biosciences Inc
7.13 Array BioPharma Inc
7.14 Axon Neuroscience SE
7.15 Beroni group
7.16 Biocad
7.17 Bioxytran Inc
7.18 Bold Therapeutics Inc
7.19 Cell-Point LLC
7.20 Celltrion Inc
7.21 CEL-SCI Corporation
7.22 Cobra Biologics Ltd
7.23 Codagenix Inc
7.24 CureVac AG
7.25 Cytovia Therapeutics
7.26 Dyadic International Inc
7.27 Emergent BioSolutions Inc
7.28 Entos Pharmaceuticals Inc
7.29 EpiVax Inc
7.30 Exscientia Ltd
7.31 Generex Biotechnology Corporation
7.32 GeoVax Labs
7.33 Grifols SA
7.34 HaloVax LLC
7.35 Hetero Labs
7.36 ImmunityBio Inc
7.37 ImmunoPrecise Antibodies Ltd
7.38 Imophoron Ltd
7.39 Innovation Pharmaceuticals Inc
7.40 Iontas
7.41 IVIEW Therapeutics Inc
7.42 Kali-extracts Inc
7.43 Kamada Ltd
7.44 Kleo Pharmaceuticals Inc
7.45 Ligandal Inc
7.46 LineaRx Inc
7.47 Mabpharm Ltd
7.48 Mateon Therapeutics Inc
7.49 NanoViricides Inc
7.50 Nascent Biotech Inc
7.51 Neurimmune AG
7.52 NuGenerex Immuno-Oncology Inc
7.53 OliX Pharmaceuticals Inc
7.54 Ology Bioservices Inc
7.55 OncoSec Medical Inc
7.56 Pfizer Inc
7.57 Pneumagen Ltd
7.58 Q BioMed Inc
7.59 Qurient Co Ltd
7.60 Regeneron Pharmaceuticals Inc
7.61 Resverlogix Corp
7.62 Sanofi SA
7.63 Sirnaomics Inc
7.64 Sirona Biochem Corp
7.65 SmartPharm Therapeutics Inc
7.66 Soligenix Inc
7.67 Sorrento Therapeutics Inc
7.68 Sosei Group Corporation
7.69 Takeda Pharmaceutical Company Ltd
7.70 Takis Biotech
7.71 Themis Bioscience GmBH
7.72 Ufovax Inc
7.73 United Biomedical Inc
7.74 Vanda Pharmaceuticals Inc
7.75 Vaxil BioTherapeutics Ltd
7.76 Vir Biotechnology Inc
7.77 Viravaxx AG
7.78 WuXi Biologics Inc
7.79 XORTX Therapeutics Inc
8 APPENDIX
8.1 ABOUT VPA RESEARCH
8.2 SOURCES AND RESEARCH METHODOLOGY
LIST OF TABLES
Table 1: COVID-19 Pipeline by Phase, April 2020
Table 2: COVID-19 Pipeline by New Molecular Entity, April- 2020
Table 3: COVID-19 Pipeline by Mechanism of Action, April 2020
Table 4: COVID-19 Pipeline by Mechanism of Action, April 2020 (Contd.)
Table 5: AstraZeneca Plc - COVID-19 Pipeline, April- 2020
Table 6: Novartis AG - COVID-19 Pipeline, April 2020
Table 7: Gilead Sciences Inc - COVID-19 Pipeline, April 2020
Table 8: FUJIFILM Toyama Chemical Co. Ltd - COVID-19 Pipeline, April 2020
Table 9: Vanda Pharmaceuticals Inc - COVID-19 Pipeline, April 2020
Table 10: Roche AG - COVID-19 Pipeline, April 2020
Table 11: OncoImmune Inc - COVID-19 Pipeline, April 2020
Table 12: Sanofi SA - COVID-19 Pipeline, April 2020
Table 13: Swedish Orphan Biovitrum AB - COVID-19 Pipeline, April 2020
Table 14: CytoDyn Inc - COVID-19 Pipeline, April 2020
Table 15: Eli Lilly and Company - COVID-19 Pipeline, April 2020
Table 16: Karyopharm Therapeutics Inc - COVID-19 Pipeline, April 2020
Table 17: Synairgen Plc - COVID-19 Pipeline, April 2020
Table 18: Bristol-Myers Squibb Co. - COVID-19 Pipeline, April 2020
Table 19: Tianjin CanSino Biotechnology - COVID-19 Pipeline, April 2020
Table 20: Kinevant Sciences Ltd- COVID-19 Pipeline, April 2020
Table 21: Vitaeris Inc - COVID-19 Pipeline, April 2020
Table 22: Relief Therapeutics Holdings - COVID-19 Pipeline, April 2020
Table 23: Viriom Inc - COVID-19 Pipeline, April 2020
Table 24: CalciMedica Inc - COVID-19 Pipeline, April 2020
Table 25: Apeiron Biologics GmbH - COVID-19 Pipeline, April 2020
Table 26: Ansun Biopharma Inc - COVID-19 Pipeline, April 2020
Table 27: I-MAB Biopharma Co Ltd - COVID-19 Pipeline, April 2020
Table 28: Moderna Therapeutics Inc- COVID-19 Pipeline, April 2020
Table 29: Ridgeback Biotherapeutics LP - COVID-19 Pipeline, April 2020
Table 30: BioCryst Pharmaceuticals Inc - COVID-19 Pipeline, April 2020
Table 31: Inovio Pharmaceuticals Inc - COVID-19 Pipeline, April 2020
Table 32: InflaRx NV - COVID-19 Pipeline, April 2020
Table 33: AIM ImmunoTech Inc- COVID-19 Pipeline, April 2020
Table 34: Arcturus Therapeutics Holdings Inc - COVID-19 Pipeline, April 2020
Table 35: ARMS Pharmaceutical LLC - COVID-19 Pipeline, April 2020
Table 36: Mateon Therapeutics Inc - COVID-19 Pipeline, April 2020
Table 37: Beyond Air Inc - COVID-19 Pipeline, April 2020
Table 38: BioNTech SE - COVID-19 Pipeline, April 2020
Table 39: Can-Fite Biopharma Ltd- COVID-19 Pipeline, April 2020
Table 40: Clover Biopharmaceuticals - COVID-19 Pipeline, April 2020
Table 41: Cocrystal Pharma Inc - COVID-19 Pipeline, April 2020
Table 42: Eiger BioPharmaceuticals Inc- COVID-19 Pipeline, April 2020
Table 43: Eli Lilly and Company - COVID-19 Pipeline, April 2020
Table 44: Ennaid Therapeutics LLC - COVID-19 Pipeline, April 2020
Table 45: Epitopoietic Research Corporation - COVID-19 Pipeline, April 2020
Table 46: EpiVax Inc - COVID-19 Pipeline, April 2020
Table 47: eTheRNA Immunotherapies NV - COVID-19 Pipeline, April 2020
Table 48: FibroGenesis - COVID-19 Pipeline, April 2020
Table 49: GigaGen Inc - COVID-19 Pipeline, April 2020
Table 50: Heat Biologics Inc - COVID-19 Pipeline, April 2020
Table 51: IBio Inc - COVID-19 Pipeline, April 2020
Table 52: Immunic Inc- COVID-19 Pipeline, April 2020
Table 53: IMV Inc - COVID-19 Pipeline, April 2020
Table 54: INTELLiSTEM Technologies Inc - COVID-19 Pipeline, April 2020
Table 55: Medicago Inc - COVID-19 Pipeline, April 2020
Table 56: MedinCell S.A. - COVID-19 Pipeline, April 2020
Table 57: BioSig Technologies Inc - COVID-19 Pipeline, April 2020
Table 58: Novavax Inc - COVID-19 Pipeline, April 2020
Table 59: OyaGen Inc - COVID-19 Pipeline, April 2020
Table 60: PDS Biotechnology Corporation - COVID-19 Pipeline, April 2020
Table 61: Primmune Therapeutics - COVID-19 Pipeline, April 2020
Table 62: SAB Biotherapeutics - COVID-19 Pipeline, April 2020
Table 63: Shanghai Junshi Biosciences - COVID-19 Pipeline, April 2020
Table 64: Sorrento Therapeutics Inc - COVID-19 Pipeline, April 2020
Table 65: Stabilitech Biopharma Ltd - COVID-19 Pipeline, April 2020
Table 66: Starpharma Holdings Limited - COVID-19 Pipeline, April 2020
Table 67: Stemirna Therapeutics Co Ltd- COVID-19 Pipeline, April 2020
Table 68: Tonix Pharmaceuticals Holding Corp. - COVID-19 Pipeline, April 2020
Table 69: Vaxart Inc- COVID-19 Pipeline, April 2020
Table 70: VBI Vaccines- COVID-19 Pipeline, April 2020
Table 71: Vir Biotechnology Inc - COVID-19 Pipeline, April 2020
Table 72: Zydus Cadila - COVID-19 Pipeline, April 2020
Table 73: 48Hour Discovery Inc - COVID-19 Pipeline, April 2020
Table 74: AbCellera Biologics Inc - COVID-19 Pipeline, April 2020
Table 75: Active Motif - COVID-19 Pipeline, April 2020
Table 76: Adaptive Biotechnologies Inc- COVID-19 Pipeline, April 2020
Table 77: AdaptVac - COVID-19 Pipeline, April 2020
Table 78: Airway Therapeutics Inc- COVID-19 Pipeline, April 2020
Table 79: AJ Vaccines - COVID-19 Pipeline, April 2020
Table 80: Akers Biosciences Inc- COVID-19 Pipeline, April 2020
Table 81: Akshaya Bio Inc- COVID-19 Pipeline, April 2020
Table 82: Alkido Pharma Inc- COVID-19 Pipeline, April 2020
Table 83: Altimmune Inc- COVID-19 Pipeline, April 2020
Table 84: Amarillo Biosciences Inc- COVID-19 Pipeline, April 2020
Table 85: Array BioPharma Inc- COVID-19 Pipeline, April 2020
Table 86: Axon Neuroscience SE- COVID-19 Pipeline, April 2020
Table 87: Beroni group - COVID-19 Pipeline, April 2020
Table 88: Biocad - COVID-19 Pipeline, April 2020
Table 89: Bioxytran Inc- COVID-19 Pipeline, April 2020
Table 90: Bold Therapeutics Inc- COVID-19 Pipeline, April 2020
Table 91: Cell-Point LLC- COVID-19 Pipeline, April 2020
Table 92: Celltrion Inc- COVID-19 Pipeline, April 2020
Table 93: CEL-SCI Corporation - COVID-19 Pipeline, April 2020
Table 94: Cobra Biologics Ltd- COVID-19 Pipeline, April 2020
Table 95: Codagenix Inc- COVID-19 Pipeline, April 2020
Table 96: CureVac AG- COVID-19 Pipeline, April 2020
Table 97: Cytovia Therapeutics - COVID-19 Pipeline, April 2020
Table 98: Dyadic International Inc- COVID-19 Pipeline, April 2020
Table 99: Emergent BioSolutions Inc- COVID-19 Pipeline, April 2020
Table 100: Entos Pharmaceuticals Inc- COVID-19 Pipeline, April 2020
Table 101: EpiVax Inc- COVID-19 Pipeline, April 2020
Table 102: Exscientia Ltd- COVID-19 Pipeline, April 2020
Table 103: Generex Biotechnology Corporation - COVID-19 Pipeline, April 2020
Table 104: GeoVax Labs - COVID-19 Pipeline, April 2020
Table 105: Grifols SA- COVID-19 Pipeline, April 2020
Table 106: HaloVax LLC- COVID-19 Pipeline, April 2020
Table 107: Hetero Labs - COVID-19 Pipeline, April 2020
Table 108: ImmunityBio Inc- COVID-19 Pipeline, April 2020
Table 109: ImmunoPrecise Antibodies Ltd- COVID-19 Pipeline, April 2020
Table 110: Imophoron Ltd- COVID-19 Pipeline, April 2020
Table 111: Innovation Pharmaceuticals Inc- COVID-19 Pipeline, April 2020
Table 112: Iontas - COVID-19 Pipeline, April 2020
Table 113: IVIEW Therapeutics Inc - COVID-19 Pipeline, April 2020
Table 114: kali-extracts Inc - COVID-19 Pipeline, April 2020
Table 115: Kamada Ltd- COVID-19 Pipeline, April 2020
Table 116: Kleo Pharmaceuticals Inc- COVID-19 Pipeline, April 2020
Table 117: Ligandal Inc- COVID-19 Pipeline, April 2020
Table 118: LineaRx Inc COVID-19 Pipeline, April 2020
Table 119: Mabpharm Ltd- COVID-19 Pipeline, April 2020
Table 120: Mateon Therapeutics Inc- COVID-19 Pipeline, April 2020
Table 121: NanoViricides Inc- COVID-19 Pipeline, April 2020
Table 122: Nascent Biotech Inc- COVID-19 Pipeline, April 2020
Table 123: Neurimmune AG - COVID-19 Pipeline, April 2020
Table 124: NuGenerex Immuno-Oncology Inc- COVID-19 Pipeline, April 2020
Table 125: OliX Pharmaceuticals Inc- COVID-19 Pipeline, April 2020
Table 126: Ology Bioservices Inc- COVID-19 Pipeline, April 2020
Table 127: OncoSec Medical Inc- COVID-19 Pipeline, April 2020
Table 128: Pfizer Inc- COVID-19 Pipeline, April 2020
Table 129: Pneumagen Ltd- COVID-19 Pipeline, April 2020
Table 130: Q BioMed Inc- COVID-19 Pipeline, April 2020
Table 131: Qurient Co Ltd - COVID-19 Pipeline, April 2020
Table 132: Regeneron Pharmaceuticals Inc- COVID-19 Pipeline, April 2020
Table 133: Resverlogix Corp- COVID-19 Pipeline, April 2020
Table 134: Sanofi SA - COVID-19 Pipeline, April 2020
Table 135: Sirnaomics Inc- COVID-19 Pipeline, April 2020
Table 136: Sirona Biochem Corp- COVID-19 Pipeline, April 2020
Table 137: SmartPharm Therapeutics Inc- COVID-19 Pipeline, April 2020
Table 138: Soligenix Inc- COVID-19 Pipeline, April 2020
Table 139: Sorrento Therapeutics Inc- COVID-19 Pipeline, April 2020
Table 140: Sosei Group Corporation- COVID-19 Pipeline, April 2020
Table 141: Takeda Pharmaceutical Company Ltd- COVID-19 Pipeline, April 2020
Table 142: Takis Biotech- COVID-19 Pipeline, April 2020
Table 143: Themis Bioscience GmBH- COVID-19 Pipeline, April 2020
Table 144: Ufovax Inc- COVID-19 Pipeline, April 2020
Table 145: United Biomedical Inc- COVID-19 Pipeline, April 2020
Table 146: Vanda Pharmaceuticals Inc- COVID-19 Pipeline, April 2020
Table 147: Vaxil BioTherapeutics Ltd- COVID-19 Pipeline, April 2020
Table 148: Vir Biotechnology Inc- COVID-19 Pipeline, April 2020
Table 149: Viravaxx AG- COVID-19 Pipeline, April 2020
Table 150: WuXi Biologics Inc- COVID-19 Pipeline, April 2020
Table 151: XORTX Therapeutics Inc- COVID-19 Pipeline, April 2020
Table 1: COVID-19 Pipeline by Phase, April 2020
Table 2: COVID-19 Pipeline by New Molecular Entity, April- 2020
Table 3: COVID-19 Pipeline by Mechanism of Action, April 2020
Table 4: COVID-19 Pipeline by Mechanism of Action, April 2020 (Contd.)
Table 5: AstraZeneca Plc - COVID-19 Pipeline, April- 2020
Table 6: Novartis AG - COVID-19 Pipeline, April 2020
Table 7: Gilead Sciences Inc - COVID-19 Pipeline, April 2020
Table 8: FUJIFILM Toyama Chemical Co. Ltd - COVID-19 Pipeline, April 2020
Table 9: Vanda Pharmaceuticals Inc - COVID-19 Pipeline, April 2020
Table 10: Roche AG - COVID-19 Pipeline, April 2020
Table 11: OncoImmune Inc - COVID-19 Pipeline, April 2020
Table 12: Sanofi SA - COVID-19 Pipeline, April 2020
Table 13: Swedish Orphan Biovitrum AB - COVID-19 Pipeline, April 2020
Table 14: CytoDyn Inc - COVID-19 Pipeline, April 2020
Table 15: Eli Lilly and Company - COVID-19 Pipeline, April 2020
Table 16: Karyopharm Therapeutics Inc - COVID-19 Pipeline, April 2020
Table 17: Synairgen Plc - COVID-19 Pipeline, April 2020
Table 18: Bristol-Myers Squibb Co. - COVID-19 Pipeline, April 2020
Table 19: Tianjin CanSino Biotechnology - COVID-19 Pipeline, April 2020
Table 20: Kinevant Sciences Ltd- COVID-19 Pipeline, April 2020
Table 21: Vitaeris Inc - COVID-19 Pipeline, April 2020
Table 22: Relief Therapeutics Holdings - COVID-19 Pipeline, April 2020
Table 23: Viriom Inc - COVID-19 Pipeline, April 2020
Table 24: CalciMedica Inc - COVID-19 Pipeline, April 2020
Table 25: Apeiron Biologics GmbH - COVID-19 Pipeline, April 2020
Table 26: Ansun Biopharma Inc - COVID-19 Pipeline, April 2020
Table 27: I-MAB Biopharma Co Ltd - COVID-19 Pipeline, April 2020
Table 28: Moderna Therapeutics Inc- COVID-19 Pipeline, April 2020
Table 29: Ridgeback Biotherapeutics LP - COVID-19 Pipeline, April 2020
Table 30: BioCryst Pharmaceuticals Inc - COVID-19 Pipeline, April 2020
Table 31: Inovio Pharmaceuticals Inc - COVID-19 Pipeline, April 2020
Table 32: InflaRx NV - COVID-19 Pipeline, April 2020
Table 33: AIM ImmunoTech Inc- COVID-19 Pipeline, April 2020
Table 34: Arcturus Therapeutics Holdings Inc - COVID-19 Pipeline, April 2020
Table 35: ARMS Pharmaceutical LLC - COVID-19 Pipeline, April 2020
Table 36: Mateon Therapeutics Inc - COVID-19 Pipeline, April 2020
Table 37: Beyond Air Inc - COVID-19 Pipeline, April 2020
Table 38: BioNTech SE - COVID-19 Pipeline, April 2020
Table 39: Can-Fite Biopharma Ltd- COVID-19 Pipeline, April 2020
Table 40: Clover Biopharmaceuticals - COVID-19 Pipeline, April 2020
Table 41: Cocrystal Pharma Inc - COVID-19 Pipeline, April 2020
Table 42: Eiger BioPharmaceuticals Inc- COVID-19 Pipeline, April 2020
Table 43: Eli Lilly and Company - COVID-19 Pipeline, April 2020
Table 44: Ennaid Therapeutics LLC - COVID-19 Pipeline, April 2020
Table 45: Epitopoietic Research Corporation - COVID-19 Pipeline, April 2020
Table 46: EpiVax Inc - COVID-19 Pipeline, April 2020
Table 47: eTheRNA Immunotherapies NV - COVID-19 Pipeline, April 2020
Table 48: FibroGenesis - COVID-19 Pipeline, April 2020
Table 49: GigaGen Inc - COVID-19 Pipeline, April 2020
Table 50: Heat Biologics Inc - COVID-19 Pipeline, April 2020
Table 51: IBio Inc - COVID-19 Pipeline, April 2020
Table 52: Immunic Inc- COVID-19 Pipeline, April 2020
Table 53: IMV Inc - COVID-19 Pipeline, April 2020
Table 54: INTELLiSTEM Technologies Inc - COVID-19 Pipeline, April 2020
Table 55: Medicago Inc - COVID-19 Pipeline, April 2020
Table 56: MedinCell S.A. - COVID-19 Pipeline, April 2020
Table 57: BioSig Technologies Inc - COVID-19 Pipeline, April 2020
Table 58: Novavax Inc - COVID-19 Pipeline, April 2020
Table 59: OyaGen Inc - COVID-19 Pipeline, April 2020
Table 60: PDS Biotechnology Corporation - COVID-19 Pipeline, April 2020
Table 61: Primmune Therapeutics - COVID-19 Pipeline, April 2020
Table 62: SAB Biotherapeutics - COVID-19 Pipeline, April 2020
Table 63: Shanghai Junshi Biosciences - COVID-19 Pipeline, April 2020
Table 64: Sorrento Therapeutics Inc - COVID-19 Pipeline, April 2020
Table 65: Stabilitech Biopharma Ltd - COVID-19 Pipeline, April 2020
Table 66: Starpharma Holdings Limited - COVID-19 Pipeline, April 2020
Table 67: Stemirna Therapeutics Co Ltd- COVID-19 Pipeline, April 2020
Table 68: Tonix Pharmaceuticals Holding Corp. - COVID-19 Pipeline, April 2020
Table 69: Vaxart Inc- COVID-19 Pipeline, April 2020
Table 70: VBI Vaccines- COVID-19 Pipeline, April 2020
Table 71: Vir Biotechnology Inc - COVID-19 Pipeline, April 2020
Table 72: Zydus Cadila - COVID-19 Pipeline, April 2020
Table 73: 48Hour Discovery Inc - COVID-19 Pipeline, April 2020
Table 74: AbCellera Biologics Inc - COVID-19 Pipeline, April 2020
Table 75: Active Motif - COVID-19 Pipeline, April 2020
Table 76: Adaptive Biotechnologies Inc- COVID-19 Pipeline, April 2020
Table 77: AdaptVac - COVID-19 Pipeline, April 2020
Table 78: Airway Therapeutics Inc- COVID-19 Pipeline, April 2020
Table 79: AJ Vaccines - COVID-19 Pipeline, April 2020
Table 80: Akers Biosciences Inc- COVID-19 Pipeline, April 2020
Table 81: Akshaya Bio Inc- COVID-19 Pipeline, April 2020
Table 82: Alkido Pharma Inc- COVID-19 Pipeline, April 2020
Table 83: Altimmune Inc- COVID-19 Pipeline, April 2020
Table 84: Amarillo Biosciences Inc- COVID-19 Pipeline, April 2020
Table 85: Array BioPharma Inc- COVID-19 Pipeline, April 2020
Table 86: Axon Neuroscience SE- COVID-19 Pipeline, April 2020
Table 87: Beroni group - COVID-19 Pipeline, April 2020
Table 88: Biocad - COVID-19 Pipeline, April 2020
Table 89: Bioxytran Inc- COVID-19 Pipeline, April 2020
Table 90: Bold Therapeutics Inc- COVID-19 Pipeline, April 2020
Table 91: Cell-Point LLC- COVID-19 Pipeline, April 2020
Table 92: Celltrion Inc- COVID-19 Pipeline, April 2020
Table 93: CEL-SCI Corporation - COVID-19 Pipeline, April 2020
Table 94: Cobra Biologics Ltd- COVID-19 Pipeline, April 2020
Table 95: Codagenix Inc- COVID-19 Pipeline, April 2020
Table 96: CureVac AG- COVID-19 Pipeline, April 2020
Table 97: Cytovia Therapeutics - COVID-19 Pipeline, April 2020
Table 98: Dyadic International Inc- COVID-19 Pipeline, April 2020
Table 99: Emergent BioSolutions Inc- COVID-19 Pipeline, April 2020
Table 100: Entos Pharmaceuticals Inc- COVID-19 Pipeline, April 2020
Table 101: EpiVax Inc- COVID-19 Pipeline, April 2020
Table 102: Exscientia Ltd- COVID-19 Pipeline, April 2020
Table 103: Generex Biotechnology Corporation - COVID-19 Pipeline, April 2020
Table 104: GeoVax Labs - COVID-19 Pipeline, April 2020
Table 105: Grifols SA- COVID-19 Pipeline, April 2020
Table 106: HaloVax LLC- COVID-19 Pipeline, April 2020
Table 107: Hetero Labs - COVID-19 Pipeline, April 2020
Table 108: ImmunityBio Inc- COVID-19 Pipeline, April 2020
Table 109: ImmunoPrecise Antibodies Ltd- COVID-19 Pipeline, April 2020
Table 110: Imophoron Ltd- COVID-19 Pipeline, April 2020
Table 111: Innovation Pharmaceuticals Inc- COVID-19 Pipeline, April 2020
Table 112: Iontas - COVID-19 Pipeline, April 2020
Table 113: IVIEW Therapeutics Inc - COVID-19 Pipeline, April 2020
Table 114: kali-extracts Inc - COVID-19 Pipeline, April 2020
Table 115: Kamada Ltd- COVID-19 Pipeline, April 2020
Table 116: Kleo Pharmaceuticals Inc- COVID-19 Pipeline, April 2020
Table 117: Ligandal Inc- COVID-19 Pipeline, April 2020
Table 118: LineaRx Inc COVID-19 Pipeline, April 2020
Table 119: Mabpharm Ltd- COVID-19 Pipeline, April 2020
Table 120: Mateon Therapeutics Inc- COVID-19 Pipeline, April 2020
Table 121: NanoViricides Inc- COVID-19 Pipeline, April 2020
Table 122: Nascent Biotech Inc- COVID-19 Pipeline, April 2020
Table 123: Neurimmune AG - COVID-19 Pipeline, April 2020
Table 124: NuGenerex Immuno-Oncology Inc- COVID-19 Pipeline, April 2020
Table 125: OliX Pharmaceuticals Inc- COVID-19 Pipeline, April 2020
Table 126: Ology Bioservices Inc- COVID-19 Pipeline, April 2020
Table 127: OncoSec Medical Inc- COVID-19 Pipeline, April 2020
Table 128: Pfizer Inc- COVID-19 Pipeline, April 2020
Table 129: Pneumagen Ltd- COVID-19 Pipeline, April 2020
Table 130: Q BioMed Inc- COVID-19 Pipeline, April 2020
Table 131: Qurient Co Ltd - COVID-19 Pipeline, April 2020
Table 132: Regeneron Pharmaceuticals Inc- COVID-19 Pipeline, April 2020
Table 133: Resverlogix Corp- COVID-19 Pipeline, April 2020
Table 134: Sanofi SA - COVID-19 Pipeline, April 2020
Table 135: Sirnaomics Inc- COVID-19 Pipeline, April 2020
Table 136: Sirona Biochem Corp- COVID-19 Pipeline, April 2020
Table 137: SmartPharm Therapeutics Inc- COVID-19 Pipeline, April 2020
Table 138: Soligenix Inc- COVID-19 Pipeline, April 2020
Table 139: Sorrento Therapeutics Inc- COVID-19 Pipeline, April 2020
Table 140: Sosei Group Corporation- COVID-19 Pipeline, April 2020
Table 141: Takeda Pharmaceutical Company Ltd- COVID-19 Pipeline, April 2020
Table 142: Takis Biotech- COVID-19 Pipeline, April 2020
Table 143: Themis Bioscience GmBH- COVID-19 Pipeline, April 2020
Table 144: Ufovax Inc- COVID-19 Pipeline, April 2020
Table 145: United Biomedical Inc- COVID-19 Pipeline, April 2020
Table 146: Vanda Pharmaceuticals Inc- COVID-19 Pipeline, April 2020
Table 147: Vaxil BioTherapeutics Ltd- COVID-19 Pipeline, April 2020
Table 148: Vir Biotechnology Inc- COVID-19 Pipeline, April 2020
Table 149: Viravaxx AG- COVID-19 Pipeline, April 2020
Table 150: WuXi Biologics Inc- COVID-19 Pipeline, April 2020
Table 151: XORTX Therapeutics Inc- COVID-19 Pipeline, April 2020
